Gilead Sciences

invented:

• Lenacapavir

  Sources: Twice-yearly lenacapavir or daily F/TAF for HIV prevention in cisgender women

Appears in3 items

• 
  HIV and AIDS3 items
  • 
    The first single-pill daily regimen · manufacturer12 Jul 2006
  • PrEP is approved · manufacturer16 Jul 2012
  • Twice-yearly lenacapavir is approved for prevention · manufacturer18 Jun 2025

Sources

1. WebsiteUS Food and Drug Administration (FDA) Approves Atripla, the First Once-Daily Single Tablet Regimen for Adults with HIV-1 Infection